HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction.
Intervirology
; 56(4): 258-64, 2013.
Article
em En
| MEDLINE
| ID: mdl-23689841
BACKGROUND: The host protein APOBEC3G (A3G) can limit HIV-1 replication. Its protective effect is overcome by the HIV-1 'viral infectivity factor' (Vif), which targets A3G for proteosomal degradation. Although Vif is considered to be essential for HIV-1 replication, the effect of Vif variability among commonly used HIV-1 molecular clones of different genetic backgrounds on viral infectiousness and pathogenesis has not been fully determined. METHODS: We cloned the intact Vif coding regions of available molecular clones of different subtypes into expression vectors. Δvif full-length HIV-1 clonal variants were generated from corresponding subtype-specific full-length molecular clones. Replication-competent viruses were produced in 293T cells in the presence or absence of A3G, with Vif being supplied by the full-length HIV-1 clone or in trans. The extent of A3G-mediated restriction was then determined in a viral replication assay using a reporter cell line. RESULTS AND CONCLUSIONS: In the absence of A3G, Vif subtype origin did not impact viral replication. In the presence of A3G the subtype origin of Vif had a differential effect on viral replication. Vif derived from a subtype C molecular clone was less effective at overcoming A3G-mediated inhibition than Vif derived from either subtype B or CRF02_AG molecular clones.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Variação Genética
/
Replicação Viral
/
HIV-1
/
Citidina Desaminase
/
Produtos do Gene vif do Vírus da Imunodeficiência Humana
Limite:
Humans
Idioma:
En
Revista:
Intervirology
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Canadá